Reset filter
Keywords
Mostra di più Keywords
Sommario
  1. 1. Test clinico
    1. 1.1. Determinazione dell`idoneità
    1. 1.2. Storia medica
    1. 1.3. Esame fisico
    1. 1.4. Punteggio di valutazione
    1. 1.5. Diagnostica Apparativa
    1. 1.6. Laboratorio
    1. 1.7. Patologia / Istologia
    1. 1.8. Consenso
    1. 1.9. Terapia
    1. 1.10. Rapporto operativo
    1. 1.11. Evento avverso
    1. 1.12. Azione supplementare
  2. 2. Documentazione di routine
  3. 3. Registro / studio di coorte
  4. 4. Garanzia di qualità
  5. 5. Dati Standard
  6. 6. Risultato segnalato dal paziente
  7. 7. Specialità mediche
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

18662 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Studie NNH Nase - Medical history (Anamnese)

- 17/09/21 - 1 modulo, 10 itemgroups, 49 elementi, 1 linguaggio
Itemgroups: Administrative Data, Basic information, Symptoms, History of nasal sinus surgery, Hypersensitivity, Other comorbidities, Obstructive sleep apnea, History of malignant diseases, Multiresistant germs and antibiotic intake, Asthma
Medical history form of the ENT department University Hospital Muenster. It contains items about hypersensitivity originating from: Top 15 DEGS Bundesgesundheitsbl 2013 · 56:687–697

Blutdosimetrie PSMA-Studie Prostatakarzinom NCT0000001

- 09/07/16 - 1 modulo, 9 itemgroups, 43 elementi, 2 lingue
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: Blutdosimetrie

Lu PSMA-Studie Prostatakarzinom NCT0000001

- 08/07/16 - 1 modulo, 9 itemgroups, 21 elementi, 2 lingue
Itemgroups: Identificaton, Session 1, Session 2, Session 3, Session 4, Session 5, Session 6, Session 7, Session 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: Lu PSMA

CTC PSMA-Studie Prostatakarzinom NCT0000001

- 08/07/16 - 1 modulo, 9 itemgroups, 101 elementi, 2 lingue
Itemgroups: Baseline, 1st Cycle, 2nd Cycle, 3rd Cycle, 4th Cycle, 5th Cycle, 6th Cycle, 7th Cycle, 8th Cycle
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: CTC

Ersterhebung OPAL-Studie DRKS00004421 NCT01619124 ALL - Ersterhebung OPAL-Studie

- 20/09/21 - 1 modulo, 6 itemgroups, 60 elementi, 2 lingue
Itemgroups: Allgemeine Angaben, Anamnese, Vorerkrankungen, Vorbehandlung (systemisch verabreicht), Befunde bei Diagnose, Bemerkungen
Osteonekrosen bei pädiatrischen Patienten mit ALL Studienleitung: Dr. M. Kuhlen, Universitätsklinikum Düsseldorf, Klinik für Kinder-­Onkologie, -­Hämatologie und Klinische Immunologie, Moorenstr. 5, 40225 Düsseldorf, Tel.: 0211 81 17687, Fax: 0211 81 04982, Email: Michaela.Kuhlen@med.uni-duesseldorf.de

Administrative Data DVMD Studie MS Baseline - Administrative Data DVMD-Studie MS Baseline

- 22/03/17 - 1 modulo, 2 itemgroups, 3 elementi, 1 linguaggio
Itemgroups: Informed Consent, Demographic Data
Multiple Sklerose Beispielstudie zur DVMD Tagung Administrative Daten Baseline

Laboratory Values PSMA-Studie Prostatakarzinom NCT0000001 - Laborwerte PSMA-Studie Prostatakarzinom NCT0000001

- 14/07/16 - 1 modulo, 9 itemgroups, 82 elementi, 2 lingue
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: Laborwerte

TER-MAG PSMA-Studie Prostatakarzinom NCT0000001

- 14/07/16 - 1 modulo, 9 itemgroups, 20 elementi, 2 lingue
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: TER-MAG

GK Dosimetrie PSMA-Studie Prostatakarzinom NCT0000001

- 09/07/16 - 1 modulo, 9 itemgroups, 57 elementi, 2 lingue
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: GK Dosimetrie

Standard Activity PSMA-Studie Prostatakarzinom NCT0000001 - Standardaktivität PSMA-Studie Prostatakarzinom NCT0000001

- 09/07/16 - 1 modulo, 9 itemgroups, 49 elementi, 2 lingue
Itemgroups: Patient Data, Cycle 1, Cycle 2, Cycle 3, Cycle 4, Cycle 5, Cycle 6, Cycle 7, Cycle 8
Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: Standardaktivität

Symptomatische Osteonekrosen OPAL-Studie DRKS00004421 NCT01619124 ALL - Symptomatische Osteonekrosen OPAL-Studie

- 20/09/21 - 1 modulo, 6 itemgroups, 75 elementi, 2 lingue
Itemgroups: Allgemeine Angaben, Nichtoperative Therapie - Analgetika, Nichtoperative Therapie - Physikalische Therapie, Nichtoperative Therapie - Medikamentöse Therapie, Operative Therapie - Gelenkerhaltende Therapie, Operative Therapie - Gelenkersatz
Osteonekrosen bei pädiatrischen Patienten mit ALL Studienleitung: Dr. M. Kuhlen, Universitätsklinikum Düsseldorf, Klinik für Kinder-­Onkologie, -­Hämatologie und Klinische Immunologie, Moorenstr. 5, 40225 Düsseldorf, Tel.: 0211 81 17687, Fax: 0211 81 04982, Email: Michaela.Kuhlen@med.uni-duesseldorf.de

Basic documentation B2 LeMLAR-Studie Lymphoma NCT01788189 - Basic documentation B2

- 15/03/21 - 1 modulo, 3 itemgroups, 26 elementi, 1 linguaggio
Itemgroups: medical history, Inclusion Criteria, Exclusion Criteria
Study part: Basic documentation B2 LeMLAR-Studie. LeMLAR-Studie. Lenalidomide in conjunction with methotrexate, leucovorin, cytarabine and rituximab for the treatment of relapsed or refractory CD20-positive aggressive lymphomas: an open-label, multicenter phase I/II trial. Publication granted by Prof. Dührsen and provided by Claudia Ose, University clinic Essen, NCT01788189, Version 1.3-28.04.2013.doc.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial